Log In
Print
BCIQ
Print
Print this Print this
 

dupilumab (REGN668, SAR231893)

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionHuman mAb targeting the alpha subunit of the IL-4 receptor (CD124)
Molecular Target Interleukin-4 (IL-4) receptor (CD124) (IL-4RA)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today